Optic atrophy due to Rosai-Dorfman disease

case report

Authors

  • María Alejandra Arriaga Sección de Neurooftalmología del Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.
  • Juan Ignacio Antonelli Sección de Neurooftalmología del Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.
  • Cintia Pineda Sección de Neurooftalmología del Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.
  • María Cecilia Cabral Lorenzo Servicio de Patología del Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.
  • Lidia Sarotto Sección de Neurooftalmología del Hospital de Clínicas José de San Martín, Buenos Aires, Argentina.

DOI:

https://doi.org/10.70313/2718.7446.v17.n03.348

Keywords:

Rosai-Dorfman disease, optic atrophy, lymphadenopathy, histiocytic proliferative disorder

Abstract

A 59-year-old man presented with decreased visual acuity and progressive hearing loss. He had a history of hypertension, poorly controlled diabetes, and nasal polyp surgery. The ophthalmologic examination showed severely reduced visual acuity in both eyes, normal intraocular pressure, and pale optic discs. The studies revealed generalized scotomas, thinning of the nerve fiber layer and ganglion cells, rhinorrhea, anosmia, and ventilatory insufficiency. Rhinoscopy identified a papillomatous lesion in both nasal cavities, and computed tomography showed soft tissue densities in several paranasal sinuses. Magnetic resonance imaging revealed diffuse tissue in the nasal cavities and paranasal sinuses, with pachymeningeal thickening near the optic nerves. A nasal sinus biopsy confirmed the diagnosis of Rosai-Dorfman disease, a rare condition characterized by benign proliferation of histiocytes in lymph nodes and extranodal tissues. This disease can manifest with massive lymphadenopathy, fever, and systemic symptoms. Ocular involvement can lead to the impairment of adjacent structures, such as the optic nerves, resulting in vision loss. PET-CT showed metabolic activity in the skeleton, suggesting active disease. Due to the rarity and severity of Rosai-Dorfman disease, a multidisciplinary team considered decompressive surgery, along with systemic anti-inflammatory and immunomodulatory treatment, to address the progression of this condition.

Downloads

Download data is not yet available.

References

McClellan SF, Ainbinder DJ. Orbital Rosai-Dorfman disease: a literature review. Orbit 2013; 32: 341-346.

Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological entity. Arch Pathol 1969; 87: 63-70.

Moore CE, Flint JH, Taniguchi KM, Gable PS. Rosai-Dorfman: rare manifestations of a rare disease. Cureus 2023; 15: e36673.

Hashimoto K, Kariya S, Onoda T et al. Rosai-Dorfman disease with extranodal involvement. Laryngoscope 2014; 124: 701-704.

Alzahem TA, Cruz AA, Maktabi AMY et al. Ophthalmic Rosai-Dorfman disease: a multi-centre comprehensive study. BMC Ophthalmol 2021; 21: 404.

Ríos Y Valles-Valles D, Herrera-Cifuentes SL, Rodríguez-Reyes AA et al. Rosai-Dorfman disease involving the eye and ocular adnexa: clinicopathologic series of 17 patients. Eur J Ophthalmol 2022; 13: 11206721221138319.

Ravindran A, Rech KL. How I diagnose Rosai-Dorfman disease. Am J Clin Pathol 2023; 160: 1-10.

Mar WA, Yu JH, Knuttinen MG et al. Rosai-Dorfman disease: manifestations outside of the head and neck. AJR Am J Roentgenol 2017; 208: 721-732.

Yazbeck M, Comair Y, Berjaoui C, Dabboucy B. Craniocervical Rosai-Dorfman disease presentation: case report and review of literature. Neurocirugia (Astur : Engl Ed) 2023; 34: 203-207.

Choi MB, Salomão DR, Smith WM et al. Ophthalmic findings of Rosai-Dorfman disease. Am J Ophthalmol 2018; 188: 164-172.

Garcia RA, DiCarlo EF. Rosai-Dorfman disease of bone and soft tissue. Arch Pathol Lab Med 2022; 146: 40-46.

Goyal G, Ravindran A, Mayo Clinic Histiocytosis Working Group et al. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica 2020; 105: 348-357.

Published

2024-09-30

Issue

Section

Case Report

How to Cite

1.
Arriaga MA, Antonelli JI, Pineda C, Cabral Lorenzo MC, Sarotto L. Optic atrophy due to Rosai-Dorfman disease: case report. Oftalmol. clín. exp. 2024;17(3):e402-e407. doi:10.70313/2718.7446.v17.n03.348

Similar Articles

1-10 of 305

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)